NL-OMON54899已完成不适用
COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in immune mediated inflammatory disease (IMID) patients, with special attention for COVID-19 - COVID I2
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Clinical diagnosis of one of a least one of the following IMIDs: Rheumatoid
- •arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA),
- •psoriasis (PsO) or inflammatory bowel disease (IBD) (i.e. Crohns disease (CD)
- •or ulcerative colitis (UC).
- •- Age >= 16 years
- •- Using one or more immunomodulating agents (IA) in any dose (agents listed in
- •- Not experiencing any clinical infection at time of inclusion
- •- Ability to read and communicate well in Dutch
排除标准
- •- Use of the following immunomodulating agents in monotherapy and through
- •intravenous administration: rituximab, tocilizumab, abatacept.
- •- Use of glucocorticoids in monotherapy
- •- Not willing to be randomized into intervention or control condition.
- •- Not being able to be followed for 12 months, because of planned relocation or
- •short life expectancy.
研究者
相似试验
已完成
4 期
COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial<p>Rheumatoid arthritis<br />Psoriatic arthritis<br />Axial spondyloarthritis<br />Immune mediated inflammatory diseases<br />Inflammatory rheumatic diseases</p>10003816NL-OMON22848Sint Maartenskliniek2,200
招募中
1 期
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, randomized, open-label, clinical trialANCA vasculitis, End-stage Renal diseaseCTIS2024-512470-10-00Centre Hospitalier Departemental Vendee136
招募中
4 期
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, randomized, open-label, clinical trial2024-512470-10-00Centre Hospitalier Departemental Vendee136
进行中（未招募）
1 期
Stopping treatment along with immune therapy in patients with HIV + who have already been treated with stem cells from each blood cells are formedEUCTR2019-001461-32-ESIrsiCaixa AIDS Research Institute
尚未招募
3 期
Effect of discontinuing immune-modulating drugs versus control group on prognosis in patients with relapsing-remitting multiple sclerosisMultiple sclerosisIRCT20120215009014N516Hamedan University of Medical Sciences178